Lv1
28 积分 2022-10-22 加入
Ultrasensitive NGS MRD assessment in Ph+ ALL : Prognostic impact and correlation with RT‐PCR for BCR::ABL1
10小时前
已完结
Posttreatment positivity of BCR::ABL1 in acute lymphoblastic leukemia: Should we keep track?
12小时前
已完结
Monitoring of childhood ALL using BCR-ABL1 genomic breakpoints identifies a subgroup with CML-like biology
2天前
已完结
Multilineage involvement in KMT2A‐rearranged B acute lymphoblastic leukaemia: cell‐of‐origin, biology, and clinical implications
8天前
已完结
Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network
2个月前
已完结
Allogeneic stem cell transplantation achieves long-term remissions in mantle cell lymphoma, including in TP53 -mutated disease
2个月前
已完结
Zanubrutinib, obinutuzumab, and venetoclax for first-line treatment of mantle cell lymphoma with a TP53 mutation
2个月前
已完结
Molecular characteristic of acute leukemias with t(16;21)/FUS-ERG
4个月前
已完结
Chronic Myeloid Leukemia
4个月前
已完结
Blinatumomab and Ponatinib for Adults with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Updated Results and Predictors of Relapse
4个月前
已关闭
皖公网安备34019202002308
